Carisma Therapeutics Inc. (CARM)

AI Score

Unlock

0.19

-0.03 (-14.49%)

At close: Apr 03, 2025, 3:59 PM

Carisma Therapeutics Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011
Revenue	n/a	14.92M	9.83M	26.54M	11.24M	n/a	n/a	425K	29.98M	990K	2.24M	1.33M	n/a	n/a
Cost of Revenue	n/a	74.13M	6.09M	85K	n/a	219K	208K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	-59.21M	3.74M	26.46M	11.24M	-219K	-208K	425K	29.98M	990K	2.24M	1.33M	n/a	n/a
Operating Income	n/a	-88.73M	-56.16M	-40.79M	-28.38M	-36.87M	-25.7M	-19.98M	6.17M	-35.2M	-33.78M	-16.63M	-19.49M	-12.68M
Interest Income	n/a	1.94M	1.85M	10K	29K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-60.48M	-86.88M	-61.23M	-40.78M	-28.35M	-107.5M	-33.69M	-29.03M	1.9M	-33.45M	-34.16M	-18.02M	-19.66M	-12.83M
Net Income	-60.48M	-86.88M	-61.23M	-40.77M	-28.32M	-107.5M	-33.69M	-29.03M	1.89M	-33.45M	-34.53M	-19.43M	-19.82M	-12.98M
Selling & General & Admin	22.14M	29.52M	3.29M	6.41M	5.09M	12.21M	11.62M	7.9M	11.44M	9.85M	8.47M	4.02M	4.21M	3.27M
Research & Development	59.67M	74.13M	56.62M	34.39M	23.29M	24.44M	13.87M	12.22M	12.2M	25.97M	26.7M	13.79M	15.26M	9.41M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	81.81M	103.65M	59.91M	40.79M	28.38M	36.65M	25.49M	20.13M	23.64M	35.82M	35.17M	17.81M	19.48M	12.68M
Interest Expense	n/a	n/a	3.15M	n/a	n/a	n/a	n/a	n/a	247K	1.4M	376K	1.4M	168K	151K
Selling & Marketing Expenses	n/a	n/a	30.41M	n/a	n/a	n/a	n/a	-170K	-3.3M	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	103.65M	66M	40.79M	28.38M	36.87M	25.7M	20.41M	23.82M	36.19M	35.17M	17.81M	19.48M	12.68M
Income Tax Expense	-60.48M	n/a	-3.88M	-10K	-29K	n/a	46.86K	n/a	5K	1.4M	376K	1.4M	168K	151K
Shares Outstanding (Basic)	41.46M	33.52M	106.4K	9.12M	5.91M	4.55M	3.09M	1.31M	1.05M	949.65K	732.2K	426.95K	355.9K	426.95K
Shares Outstanding (Diluted)	41.46M	33.52M	106.4K	9.12M	5.91M	4.55M	3.09M	1.31M	1.09M	949.65K	732.2K	426.95K	355.9K	426.95K
EPS (Basic)	-1.46	-2.59	-575.42	-4.47	-4.79	-23.64	-10.91	-22.24	1.79	-35.23	-47.16	-45.5	-55.7	-30.39
EPS (Diluted)	-1.46	-2.59	-575.42	-4.47	-4.79	-23.64	-10.91	-22.24	1.74	-35.23	-47.16	-45.5	-55.7	-30.39
EBITDA	n/a	-85.89M	-51.99M	-40.11M	-27.93M	-107.28M	-33.48M	-28.74M	2.32M	-31.69M	-33.37M	-17.18M	-19.04M	-12.31M
EBIT	n/a	-88.73M	-58.08M	-40.79M	-28.38M	-107.5M	-33.69M	-29.03M	2.14M	-32.06M	-33.78M	-17.62M	-19.49M	-12.68M
Depreciation & Amortization	n/a	2.84M	6.09M	85K	122K	219K	208K	285K	178K	366K	410K	438K	448K	364K